-
21
Short-Term Efficacy of Exclusive Enteral Nutrition in Pediatric Crohn’s Disease: Practice in China
Published 2015-01-01“…Patients who were followed up for more than 2 months with mild to moderate disease were included. Basic demographics, history, physical examination, the pediatric Crohn disease activity index (PCDAI), laboratory findings, endoscopic findings, and adverse effects were recorded. …”
Get full text
Article -
22
Application of Spectral Computed Tomography Single-energy Technique to Small Bowel Crohn’s Disease
Published 2025-01-01“…Differences in imaging features of Crohn’s disease activity were determined using the paired \begin{document}$\chi^2 $\end{document} test. …”
Get full text
Article -
23
The simplified GLIM criteria for assessment of malnutrition and its correlation with clinical outcomes in Crohn’s disease patients
Published 2025-01-01“…The malnourished group had significantly higher Crohn’s Disease Activity Index (CDAI) scores compared to the non-malnourished group (p < 0.001). …”
Get full text
Article -
24
Responsiveness and clinical utility of PROMIS instruments in pediatric Crohn's disease: insights from a longitudinal study
Published 2025-01-01“…PROMIS pediatric measures assessed PROs. Disease activity was evaluated using the pediatric Crohn's disease activity index (PCDAI) and clinical markers. …”
Get full text
Article -
25
Outcomes of Pediatric Patients with Crohn’s Disease Received Infliximab or Exclusive Enteral Nutrition during Induction Remission
Published 2022-01-01“…Medical records of newly diagnosed, therapy naïve pediatric patients with CD received with IFX or EEN as induction therapy were retrospectively enrolled. Pediatric Crohn’s disease activity index (PCDAI), Crohn’s disease endoscopic index of severity (CDEIS), and other clinical data were compared pre- and postinduction therapy in two groups. …”
Get full text
Article -
26
-
27
Assessment of the Utility of Selected Inflammatory Markers in Correlation with Magnetic Resonance Enterography (MRE) Findings in the Diagnosis of Crohn’s Disease
Published 2025-01-01“…We performed the analysis of cytokine concentrations in blood serum using the Bio-Plex Multiplex system (Bio-Rad), and their correlations with radiological parameters were assessed by magnetic resonance enterography (MRE), and fecal calprotectin levels were measured quantitatively by ELISA and clinical evaluation according to the Crohn’s Disease Activity Index (CDAI). Our study found that measuring cytokine serum concentrations can be a valuable tool in the diagnosis and treatment of CD. …”
Get full text
Article -
28
Adalimumab Treatment in Biologically Naïve Crohn’s Disease: Relationship with Ectopic MUC5AC Expression and Endoscopic Improvement
Published 2014-01-01“…Results. Both mean CD activity index scores and serum C-reactive protein values were significantly lower after ADA therapy (P<0.001). …”
Get full text
Article -
29
Course of COVID-19 in Patients with Inflammatory Bowel Disease: Regional Experience
Published 2023-02-01“…Ulcerative colitis (UC) was diagnosed in 60 (59.4 %) patients, Crohn's disease (CD) — in 41 (40.6 %) patients. The mean age of the patients was 41.0 ± 14.7 years, of which 59 (58.4 %) were men and 42 (41.6 %) were women. …”
Get full text
Article -
30
The Relationship between C-Reactive Protein/Albumin Ratio and Disease Activity in Patients with Inflammatory Bowel Disease
Published 2020-01-01“…To explore the disease activity, the Mayo score and Crohn disease activity index were used to assess UC and CD patients, respectively. …”
Get full text
Article -
31
Listeria Rhombencephalitis Complicating Anti-TNF Treatment during an Acute Flare of Crohn’s Colitis
Published 2016-01-01“…Patients with Crohn’s disease often require the use of immunosuppressant drugs to control disease activity. …”
Get full text
Article -
32
Fluticasone Propionate in Inflammatory Bowel Disease
Published 1990-01-01“…In particular, fluitcasone propionate is a fluorinated glucocorticoid, in which systemic side effects are absent or minimal due to its relatively low absorption and rapid first pass metabolism In an open trial in 12 patients with mild and moderately active Crohn's disease, administration of 20 mg fluitcasone propionate orally was associated with a significant fall in the Crohn's disease activity index and improvement in other parameters of inflammation, without change in either plasma cortisol levels or responsiveness to adrenocorticotropic hormone, suggesting that this drug is a promising therapy for Crohn's disease meriting evaluation against conventional corticosteroids.…”
Get full text
Article -
33
The Relationship between Serum Bilirubin and Inflammatory Bowel Disease
Published 2019-01-01“…The Crohn’s Disease Activity Index (CDAI) score was used to assess disease activity in patients with CD and the Mayo score of patients with UC. 255 clinically healthy subjects comprised the control group, which come from the same geographic area as the IBD group. …”
Get full text
Article -
34
Reduction of depressive symptoms among patients with inflammatory bowel disease treated with biological therapy: a quantitative comparative incision study
Published 2019-06-01“…Instruments: Ulcerative colitis activity index, Crohn’s disease activity index, the subscale of neurovegetative depression symptoms of the Beck depression inventory, and Hospital anxiety and depression scale. …”
Get full text
Article -
35
-
36
Rapamycin Alleviates 2,4,6-Trinitrobenzene Sulfonic Acid-Induced Colitis through Autophagy Induction and NF-κB Pathway Inhibition in Mice
Published 2022-01-01“…TNBS-induced colitis mice were treated with saline or rapamycin, and the disease activity index (DAI) and histological scores of colonic mucosa were evaluated. …”
Get full text
Article
